ASX:ACW

Actinogen Medical Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume275,000 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Actinogen Medical (ASX:ACW) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying ACW stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Actinogen Medical, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Actinogen Medical vs. (CHV) Stock

(CHV) (CNSX:CHV) and Actinogen Medical (ASX:ACW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Earnings and Valuation

This table compares (CHV) and Actinogen Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(CHV)	N/A	N/A	N/A	N/A	N/A
Actinogen Medical	$2.84 million	0.00	$-4,981,680.00	A$0.00	N/A

(CHV) has higher earnings, but lower revenue than Actinogen Medical.

Profitability

This table compares (CHV) and Actinogen Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(CHV)	N/A	N/A	N/A
Actinogen Medical	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current ratings and price targets for (CHV) and Actinogen Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(CHV)	0	0	0	0	N/A
Actinogen Medical	0	0	0	0	N/A

Summary

Actinogen Medical beats (CHV) on 1 of the 1 factors compared between the two stocks.

Actinogen Medical vs. (DDXS) Stock

(DDXS) (OTCMKTS:DDXS) and Actinogen Medical (ASX:ACW) are both health technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Earnings & Valuation

This table compares (DDXS) and Actinogen Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Actinogen Medical	$2.84 million	0.00	$-4,981,680.00	A$0.00	N/A

(DDXS) has higher earnings, but lower revenue than Actinogen Medical.

Profitability

This table compares (DDXS) and Actinogen Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Actinogen Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for (DDXS) and Actinogen Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Actinogen Medical	0	0	0	0	N/A

Summary

Actinogen Medical beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Actinogen Medical vs. (PREV) Stock

(PREV) (CNSX:PREV) and Actinogen Medical (ASX:ACW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Earnings & Valuation

This table compares (PREV) and Actinogen Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Actinogen Medical	$2.84 million	0.00	$-4,981,680.00	A$0.00	N/A

(PREV) has higher earnings, but lower revenue than Actinogen Medical.

Profitability

This table compares (PREV) and Actinogen Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Actinogen Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for (PREV) and Actinogen Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Actinogen Medical	0	0	0	0	N/A

Summary

Actinogen Medical beats (PREV) on 1 of the 1 factors compared between the two stocks.

Actinogen Medical vs. (TNGN) Stock

(TNGN) (OTCMKTS:TNGN) and Actinogen Medical (ASX:ACW) are both health technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Earnings & Valuation

This table compares (TNGN) and Actinogen Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(TNGN)	N/A	N/A	N/A	N/A	N/A
Actinogen Medical	$2.84 million	0.00	$-4,981,680.00	A$0.00	N/A

(TNGN) has higher earnings, but lower revenue than Actinogen Medical.

Profitability

This table compares (TNGN) and Actinogen Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(TNGN)	N/A	N/A	N/A
Actinogen Medical	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for (TNGN) and Actinogen Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(TNGN)	0	0	0	0	N/A
Actinogen Medical	0	0	0	0	N/A

Summary

Actinogen Medical beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Actinogen Medical vs. 138267 (COM.TO) Stock

138267 (COM.TO) (TSE:COM) and Actinogen Medical (ASX:ACW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings and recommmendations for 138267 (COM.TO) and Actinogen Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
138267 (COM.TO)	0	0	0	0	N/A
Actinogen Medical	0	0	0	0	N/A

Earnings & Valuation

This table compares 138267 (COM.TO) and Actinogen Medical's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A
Actinogen Medical	$2.84 million	0.00	$-4,981,680.00	A$0.00	N/A

138267 (COM.TO) has higher earnings, but lower revenue than Actinogen Medical.

Profitability

This table compares 138267 (COM.TO) and Actinogen Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
138267 (COM.TO)	N/A	N/A	N/A
Actinogen Medical	N/A	N/A	N/A

Summary

Actinogen Medical beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Actinogen Medical vs. 17031 Stock

Actinogen Medical (ASX:ACW) and 17031 (CNSX:MYM) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Analyst Ratings

This is a summary of current recommendations for Actinogen Medical and 17031, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Actinogen Medical	0	0	0	0	N/A
17031	0	0	0	0	N/A

Valuation & Earnings

This table compares Actinogen Medical and 17031's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Actinogen Medical	$2.84 million	0.00	C$-4,981,680.00	A$0.00	N/A
17031	N/A	N/A	N/A	N/A	N/A

17031 has lower revenue, but higher earnings than Actinogen Medical.

Profitability

This table compares Actinogen Medical and 17031's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Actinogen Medical	N/A	N/A	N/A
17031	N/A	N/A	N/A

Summary

Actinogen Medical beats 17031 on 1 of the 1 factors compared between the two stocks.